Bladder Cancer Advocacy Network (BCAN)

Viewing 1-14 of 14 articles

BCAN 2019: Genomics in Bladder Cancer

BCAN 2019: Integrated Mutation Profiling of Actionable Cancer Targets (IMPACT)

BCAN 2019: The Biomarker Discovery Process for Bladder Cancer

BCAN 2019: FDA Collaboration with the Bladder Cancer Community

BCAN 2019: Proteogenomic Characterization of Muscle-invasive Bladder Cancer

BCAN 2019: Race and Guideline Based Treatment in Bladder Cancer

BCAN 2019: FDA Approval of Therapies in the Context of BCG Shortages and Alternative Therapies

BCAN 2019: Diagnostic Approach in Clinically Node Positive Bladder Cancer

BCAN 2019: FDA Collaboration in Adjuvant Trials in Muscle Invasive Bladder Cancer

BCAN 2019: Palliative Care Use Amongst Patients With Bladder Cancer

BCAN 2019: Radiographic Consideration Prior to Clinical Trial Enrollment

BCAN 2019: The Introduction of Palliative Care in Bladder Cancer

BCAN 2019: How Urology Can Improve Implementation and Dissemination of Palliative Care in Bladder Cancer

Collaborating to Move Research Forward - 2019 BCAN Think Tank

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.